The DOI matches its Crossref record; 150 of the 150 references it cites were found in a registry or an index.
B cells and antibodies in multiple sclerosis pathogenesis and therapy
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Lymphocyte egress from thymus and peripheral lymphoid organs is dependent on S1P receptor 1
Matloubian, M., Lo, C. G., Cinamon, G., Lesneski, M. J., Xu, Y., Brinkmann, V., Allende, M. L., Proia, R. L., & Cyster, J. G. (2004) · Nature · doi:10.1038/nature02284 · Cited by 2,581
The many roles of chemokines and chemokine receptors in inflammation
Charo, I. F., & Ransohoff, R. M. (2006) · New England Journal of Medicine · doi:10.1056/nejmra052723 · Cited by 2,523
B-cell depletion with rituximab in relapsing-remitting multiple sclerosis
Hauser, S. L., Waubant, E., Arnold, D. L., Vollmer, T., Antel, J., Fox, R. J., Bar-Or, A., Panzara, M., Sarkar, N., Agarwal, S., et al. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa0706383 · Cited by 2,439
Cortical demyelination and diffuse white matter injury in multiple sclerosis
Kutzelnigg, A., Lucchinetti, C. F., Stadelmann, C., Brück, W., Rauschka, H., Bergmann, M., Schmidbauer, M., Parisi, J. E., & Lassmann, H. (2005) · Brain · doi:10.1093/brain/awh641 · Cited by 1,836
B cells regulate autoimmunity by provision of IL-10
Fillatreau, S., Sweenie, C. H., McGeachy, M. J., Gray, D., & Anderton, S. M. (2002) · Nature Immunology · doi:10.1038/ni833 · Cited by 1,647
Serafini, B., Rosicarelli, B., Magliozzi, R., Stigliano, E., & Aloisi, F. (2004) · Brain Pathology · doi:10.1111/j.1750-3639.2004.tb00049.x · Cited by 1,208
Modulatory Effects of 1,25-Dihydroxyvitamin D3 on Human B Cell Differentiation
Chen, S., Sims, G. P., Chen, X. X., Gu, Y. Y., Chen, S., & Lipsky, P. E. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.179.3.1634 · Cited by 1,119
Iwata, Y., Matsushita, T., Horikawa, M., DiLillo, D. J., Yanaba, K., Venturi, G. M., Szabolcs, P. M., Bernstein, S. H., Magro, C. M., Williams, A. D., et al. (2011) · Blood · doi:10.1182/blood-2010-07-294249 · Cited by 1,104
Inflammatory cortical demyelination in early multiple sclerosis.
Lucchinetti, C. F., Popescu, B. F. G., Bunyan, R. F., Moll, N. M., Roemer, S. F., Lassmann, H., Brück, W., Parisi, J. E., Scheithauer, B. W., Giannini, C., et al. (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1100648 · Cited by 1,103
Alemtuzumab vs. Interferon Beta-1a in Early Multiple Sclerosis
(2008) · New England Journal of Medicine · doi:10.1056/nejmoa0802670 · Cited by 1,017
The anatomical and cellular basis of immune surveillance in the central nervous system
Ransohoff, R. M., & Engelhardt, B. (2012) · Nature Reviews Immunology · doi:10.1038/nri3265 · Cited by 972
Hawker, K., O'Connor, P., Freedman, M. S., Calabresi, P. A., Antel, J., Simon, J., Hauser, S., Waubant, E., Vollmer, T., Panitch, H., et al. (2009) · Annals of Neurology · doi:10.1002/ana.21867 · Cited by 934
Mackay, F., & Schneider, P. (2009) · Nature Reviews Immunology · doi:10.1038/nri2572 · Cited by 930
Meningeal inflammation is widespread and linked to cortical pathology in multiple sclerosis
Howell, O. W., Reeves, C. A., Nicholas, R., Carassiti, D., Radotra, B., Gentleman, S. M., Serafini, B., Aloisi, F., Roncaroli, F., Magliozzi, R., et al. (2011) · Brain · doi:10.1093/brain/awr182 · Cited by 858
Kappos, L., Li, D., Calabresi, P. A., O'Connor, P., Bar-Or, A., Barkhof, F., Yin, M., Leppert, D., Glanzman, R., Tinbergen, J., et al. (2011) · The Lancet · doi:10.1016/s0140-6736(11)61649-8 · Cited by 743
B cell depletion therapy ameliorates autoimmune disease through ablation of IL-6–producing B cells
Barr, T. A., Shen, P., Brown, S., Lampropoulou, V., Roch, T., Lawrie, S., Fan, B., O’Connor, R. A., Anderton, S. M., Bar-Or, A., et al. (2012) · Journal of Experimental Medicine · doi:10.1084/jem.20111675 · Cited by 649
Finding a way out: lymphocyte egress from lymphoid organs
Schwab, S. R., & Cyster, J. G. (2007) · Nature Immunology · doi:10.1038/ni1545 · Cited by 605
Krumbholz, M., Theil, D., Cepok, S., Hemmer, B., Kivisäkk, P., Ransohoff, R. M., Hofbauer, M., Farina, C., Derfuss, T., Hartle, C., et al. (2006) · Brain · doi:10.1093/brain/awh680 · Cited by 561
Self-citationFollicular shuttling of marginal zone B cells facilitates antigen transport
Cinamon, G., Zachariah, M. A., Lam, O. M., Foss, F. W., & Cyster, J. G. (2008) · Nature Immunology · doi:10.1038/ni1542 · Cited by 543
Anti-Inflammatory Actions of Intravenous Immunoglobulin
Nimmerjahn, F., & Ravetch, J. V. (2008) · Annual Review of Immunology · doi:10.1146/annurev.immunol.26.021607.090232 · Cited by 525
Krumbholz, M., Theil, D., Derfuss, T., Rosenwald, A., Schrader, F., Monoranu, C.-M., Kalled, S. L., Hess, D. M., Serafini, B., Aloisi, F., et al. (2005) · The Journal of Experimental Medicine · doi:10.1084/jem.20041674 · Cited by 492
Self-citationRituximab reduces B cells and T cells in cerebrospinal fluid of multiple sclerosis patients
Cross, A. H., Stark, J. L., Lauber, J., Ramsbottom, M. J., & Lyons, J.-A. (2006) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2006.06.029 · Cited by 454
Mader, S., Gredler, V., Schanda, K., Rostasy, K., Dujmovic, I., Pfaller, K., Lutterotti, A., Jarius, S., Di Pauli, F., Kuenz, B., et al. (2011) · Journal of Neuroinflammation · doi:10.1186/1742-2094-8-184 · Cited by 449
Kirk, A. D., Hale, D. A., Mannon, R. B., Kleiner, D. E., Hoffmann, S. C., Kampen, R. L., Cendales, L. K., Tadaki, D. K., Harlan, D. M., & Swanson, S. J. (2003) · Transplantation · doi:10.1097/01.tp.0000071362.99021.d9 · Cited by 436
Immune surveillance in multiple sclerosis patients treated with natalizumab
Stüve, O., Marra, C. M., Jerome, K. R., Cook, L., Cravens, P. D., Cepok, S., Frohman, E. M., Phillips, J. T., Arendt, G., Hemmer, B., et al. (2006) · Annals of Neurology · doi:10.1002/ana.20858 · Cited by 434
Keegan, M., König, F., McClelland, R., Brück, W., Morales, Y., Bitsch, A., Panitch, H., Lassmann, H., Weinshenker, B., Rodriguez, M., et al. (2005) · The Lancet · doi:10.1016/s0140-6736(05)67102-4 · Cited by 433
AQP4 antibodies in neuromyelitis optica: diagnostic and pathogenetic relevance
Jarius, S., & Wildemann, B. (2010) · Nature Reviews Neurology · doi:10.1038/nrneurol.2010.72 · Cited by 423
Sphingosine 1-phosphate receptor 1 promotes B cell localization in the splenic marginal zone
Cinamon, G., Matloubian, M., Lesneski, M. J., Xu, Y., Low, C., Lu, T., Proia, R. L., & Cyster, J. G. (2004) · Nature Immunology · doi:10.1038/ni1083 · Cited by 418
Self-antigen tetramers discriminate between myelin autoantibodies to native or denatured protein
O'Connor, K. C., McLaughlin, K. A., De Jager, P. L., Chitnis, T., Bettelli, E., Xu, C., Robinson, W. H., Cherry, S. V., Bar-Or, A., Banwell, B., et al. (2007) · Nature Medicine · doi:10.1038/nm1488 · Cited by 416
Neurofascin as a novel target for autoantibody-mediated axonal injury
Mathey, E. K., Derfuss, T., Storch, M. K., Williams, K. R., Hales, K., Woolley, D. R., Al-Hayani, A., Davies, S. N., Rasband, M. N., Olsson, T., et al. (2007) · The Journal of Experimental Medicine · doi:10.1084/jem.20071053 · Cited by 390
Self-citationLong-lived autoreactive plasma cells drive persistent autoimmune inflammation
Hiepe, F., Dörner, T., Hauser, A. E., Hoyer, B. F., Mei, H., & Radbruch, A. (2011) · Nature Reviews Rheumatology · doi:10.1038/nrrheum.2011.1 · Cited by 389
B CELL IMMUNOBIOLOGY IN DISEASE: Evolving Concepts from the Clinic
Martin, F., & Chan, A. C. (2006) · Annual Review of Immunology · doi:10.1146/annurev.immunol.24.021605.090517 · Cited by 369
Cepok, S., Rosche, B., Grummel, V., Vogel, F., Zhou, D., Sayn, J., Sommer, N., Hartung, H.-P., & Hemmer, B. (2005) · Brain · doi:10.1093/brain/awh486 · Cited by 367
Homogeneity of active demyelinating lesions in established multiple sclerosis
Breij, E. C. W., Brink, B. P., Veerhuis, R., van den Berg, C., Vloet, R., Yan, R., Dijkstra, C. D., van der Valk, P., & Bö, L. (2008) · Annals of Neurology · doi:10.1002/ana.21311 · Cited by 353
Corcione, A., Casazza, S., Ferretti, E., Giunti, D., Zappia, E., Pistorio, A., Gambini, C., Mancardi, G. L., Uccelli, A., & Pistoia, V. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0402455101 · Cited by 349
Potassium Channel KIR4.1 as an Immune Target in Multiple Sclerosis
Srivastava, R., Aslam, M., Kalluri, S. R., Schirmer, L., Buck, D., Tackenberg, B., Rothhammer, V., Chan, A., Gold, R., Berthele, A., et al. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1110740 · Cited by 343
Tobacco smoking, but not Swedish snuff use, increases the risk of multiple sclerosis
Hedström, A. K., Bäärnhielm, M., Olsson, T., & Alfredsson, L. (2009) · Neurology · doi:10.1212/wnl.0b013e3181b59c40 · Cited by 323
Palace, J., Leite, M. I., Nairne, A., & Vincent, A. (2010) · Archives of Neurology · doi:10.1001/archneurol.2010.188 · Cited by 322
Qin, Y., Duquette, P., Zhang, Y., Talbot, P., Poole, R., & Antel, J. (1998) · Journal of Clinical Investigation · doi:10.1172/jci3568 · Cited by 320
Weber, M. S., Prod'homme, T., Patarroyo, J. C., Molnarfi, N., Karnezis, T., Lehmann‐Horn, K., Danilenko, D. M., Eastham‐Anderson, J., Slavin, A. J., Linington, C., et al. (2010) · Annals of Neurology · doi:10.1002/ana.22081 · Cited by 318
Lipid microarrays identify key mediators of autoimmune brain inflammation
Kanter, J. L., Narayana, S., Ho, P. P., Catz, I., Warren, K. G., Sobel, R. A., Steinman, L., & Robinson, W. H. (2006) · Nature Medicine · doi:10.1038/nm1344 · Cited by 317
Antibody facilitation of multiple sclerosis-like lesions in a nonhuman primate.
Genain, C. P., Nguyen, M. H., Letvin, N. L., Pearl, R., Davis, R. L., Adelman, M., Lees, M. B., Linington, C., & Hauser, S. L. (1995) · Journal of Clinical Investigation · doi:10.1172/jci118368 · Cited by 314
Meinl, E., Krumbholz, M., & Hohlfeld, R. (2006) · Annals of Neurology · doi:10.1002/ana.20890 · Cited by 310
Self-citationAntibodies to MOG are transient in childhood acute disseminated encephalomyelitis
Pröbstel, A. K., Dornmair, K., Bittner, R., Sperl, P., Jenne, D., Magalhaes, S., Villalobos, A., Breithaupt, C., Weissert, R., Jacob, U., et al. (2011) · Neurology · doi:10.1212/wnl.0b013e318228c0b1 · Cited by 306
Self-citationLong-term follow-up of patients with neuromyelitis optica after repeated therapy with rituximab
Pellkofer, H. L., Krumbholz, M., Berthele, A., Hemmer, B., Gerdes, L. A., Havla, J., Bittner, R., Canis, M., Meinl, E., Hohlfeld, R., et al. (2011) · Neurology · doi:10.1212/wnl.0b013e3182152881 · Cited by 296
Self-citationSmoking and Multiple Sclerosis: An Updated Meta-Analysis
Handel, A. E., Williamson, A. J., Disanto, G., Dobson, R., Giovannoni, G., & Ramagopalan, S. V. (2011) · PLoS ONE · doi:10.1371/journal.pone.0016149 · Cited by 296
Pöllinger, B., Krishnamoorthy, G., Berer, K., Lassmann, H., Bösl, M. R., Dunn, R., Domingues, H. S., Holz, A., Kurschus, F. C., & Wekerle, H. (2009) · Journal of Experimental Medicine · doi:10.1084/jem.20090299 · Cited by 296
Kim, S.-H. (2011) · Archives of Neurology · doi:10.1001/archneurol.2011.154 · Cited by 295
B Cell Repertoire Diversity and Clonal Expansion in Multiple Sclerosis Brain Lesions
Baranzini, S. E., Jeong, M. C., Butunoi, C., Murray, R. S., Bernard, C. C. A., & Oksenberg, J. R. (1999) · The Journal of Immunology · doi:10.4049/jimmunol.163.9.5133 · Cited by 294
Obermeier, B., Mentele, R., Malotka, J., Kellermann, J., Kümpfel, T., Wekerle, H., Lottspeich, F., Hohlfeld, R., & Dornmair, K. (2008) · Nature Medicine · doi:10.1038/nm1714 · Cited by 292
Self-citationThe initiation and prevention of multiple sclerosis
Ascherio, A., Munger, K. L., & Lünemann, J. D. (2012) · Nature Reviews Neurology · doi:10.1038/nrneurol.2012.198 · Cited by 289
Vitamin D and autoimmune thyroid diseases
Kivity, S., Agmon-Levin, N., Zisappl, M., Shapira, Y., Nagy, E. V., Dankó, K., Szekanecz, Z., Langevitz, P., & Shoenfeld, Y. (2011) · Cellular & Molecular Immunology · doi:10.1038/cmi.2010.73 · Cited by 285
Changes in B- and T-Lymphocyte and Chemokine Levels With Rituximab Treatment in Multiple Sclerosis
Piccio, L., Naismith, R. T., Trinkaus, K., Klein, R. S., Parks, B. J., Lyons, J. A., & Cross, A. H. (2010) · Archives of Neurology · doi:10.1001/archneurol.2010.99 · Cited by 274
Alemtuzumab more effective than interferon β-1a at 5-year follow-up of CAMMS223 Clinical Trial
Coles, A. J., Fox, E., Vladic, A., Gazda, S. K., Brinar, V., Selmaj, K. W., Skoromets, A., Stolyarov, I., Bass, A., Sullivan, H., et al. (2012) · Neurology · doi:10.1212/wnl.0b013e31824e8ee7 · Cited by 268
Regulated Expression of BAFF-Binding Receptors during Human B Cell Differentiation
Darce, J. R., Arendt, B. K., Wu, X., & Jelinek, D. F. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.179.11.7276 · Cited by 264
Environmental factors and their timing in adult-onset multiple sclerosis
Handel, A. E., Giovannoni, G., Ebers, G. C., & Ramagopalan, S. V. (2010) · Nature Reviews Neurology · doi:10.1038/nrneurol.2010.1 · Cited by 263
Khademi, M., Kockum, I., Andersson, M. L., Iacobaeus, E., Brundin, L., Sellebjerg, F., Hillert, J., Piehl, F., & Olsson, T. (2011) · Multiple Sclerosis Journal · doi:10.1177/1352458510389102 · Cited by 261
Villar, L. M., Sádaba, M. C., Roldán, E., Masjuan, J., González-Porqué, P., Villarrubia, N., Espiño, M., García-Trujillo, J. A., Bootello, A., & Álvarez-Cermeño, J. C. (2005) · Journal of Clinical Investigation · doi:10.1172/jci200522833 · Cited by 259
Smoking and Disease Progression in Multiple Sclerosis
Healy, B. C., Ali, E. N., Guttmann, C. R. G., Chitnis, T., Glanz, B. I., Buckle, G., Houtchens, M., Stazzone, L., Moodie, J., Berger, A. M., et al. (2009) · Archives of Neurology · doi:10.1001/archneurol.2009.122 · Cited by 244
Yang, M., Sun, L., Wang, S., Ko, K.-H., Xu, H., Zheng, B.-J., Cao, X., & Lu, L. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.0902551 · Cited by 242
Patterns of cerebrospinal fluid pathology correlate with disease progression in multiple sclerosis
Cepok, S. (2001) · Brain · doi:10.1093/brain/124.11.2169 · Cited by 242
Quintana, F. J., Farez, M. F., Viglietta, V., Iglesias, A. H., Merbl, Y., Izquierdo, G., Lucas, M., Basso, A. S., Khoury, S. J., Lucchinetti, C. F., et al. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0806310105 · Cited by 241
B-Cell Reconstitution and BAFF After Alemtuzumab (Campath-1H) Treatment of Multiple Sclerosis
Thompson, S. A. J., Jones, J. L., Cox, A. L., Compston, D. A. S., & Coles, A. J. (2010) · Journal of Clinical Immunology · doi:10.1007/s10875-009-9327-3 · Cited by 232
Cambridge, G., Leandro, M. J., Teodorescu, M., Manson, J., Rahman, A., Isenberg, D. A., & Edwards, J. C. (2006) · Arthritis & Rheumatism · doi:10.1002/art.22211 · Cited by 230
CXCL13 is the major determinant for B cell recruitment to the CSF during neuroinflammation
Kowarik, M. C., Cepok, S., Sellner, J., Grummel, V., Weber, M. S., Korn, T., Berthele, A., & Hemmer, B. (2012) · Journal of Neuroinflammation · doi:10.1186/1742-2094-9-93 · Cited by 224
Related B cell clones populate the meninges and parenchyma of patients with multiple sclerosis
Lovato, L., Willis, S. N., Rodig, S. J., Caron, T., Almendinger, S. E., Howell, O. W., Reynolds, R., O’Connor, K. C., & Hafler, D. A. (2011) · Brain · doi:10.1093/brain/awq350 · Cited by 223
Derfuss, T., Parikh, K., Velhin, S., Braun, M., Mathey, E., Krumbholz, M., Kümpfel, T., Moldenhauer, A., Rader, C., Sonderegger, P., et al. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0901496106 · Cited by 221
Self-citationPers, J., Devauchelle, V., Daridon, C., Bendaoud, B., Berre, R. L., Bordron, A., Hutin, P., Renaudineau, Y., Dueymes, M., Loisel, S., et al. (2007) · Arthritis & Rheumatism · doi:10.1002/art.22603 · Cited by 221
Plasma cell S1P1 expression determines secondary lymphoid organ retention versus bone marrow tropism
Kabashima, K., Haynes, N. M., Xu, Y., Nutt, S. L., Allende, M. L., Proia, R. L., & Cyster, J. G. (2006) · The Journal of Experimental Medicine · doi:10.1084/jem.20061289 · Cited by 220
Autoimmune disease after alemtuzumab treatment for multiple sclerosis in a multicenter cohort
Cossburn, M., Pace, A. A., Jones, J., Ali, R., Ingram, G., Baker, K., Hirst, C., Zajicek, J., Scolding, N., Boggild, M., et al. (2011) · Neurology · doi:10.1212/wnl.0b013e318228bec5 · Cited by 216
Tak, P. P., Thurlings, R. M., Rossier, C., Nestorov, I., Dimic, A., Mircetic, V., Rischmueller, M., Nasonov, E., Shmidt, E., Emery, P., et al. (2008) · Arthritis & Rheumatism · doi:10.1002/art.23178 · Cited by 207
Natalizumab disproportionately increases circulating pre-B and B cells in multiple sclerosis
Krumbholz, M., Meinl, I., Kümpfel, T., Hohlfeld, R., & Meinl, E. (2008) · Neurology · doi:10.1212/01.wnl.0000327671.91357.96 · Cited by 194
Self-citationVallerskog, T., Heimbürger, M., Gunnarsson, I., Zhou, W., Wahren-Herlenius, M., Trollmo, C., & Malmström, V. (2006) · Arthritis Research & Therapy · doi:10.1186/ar2076 · Cited by 190
Age-Dependent B Cell Autoimmunity to a Myelin Surface Antigen in Pediatric Multiple Sclerosis
McLaughlin, K. A., Chitnis, T., Newcombe, J., Franz, B., Kennedy, J., McArdel, S., Kuhle, J., Kappos, L., Rostasy, K., Pohl, D., et al. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0801888 · Cited by 189
Antibodies produced by clonally expanded plasma cells in multiple sclerosis cerebrospinal fluid
Owens, G. P., Bennett, J. L., Lassmann, H., O'Connor, K. C., Ritchie, A. M., Shearer, A., Lam, C., Yu, X., Birlea, M., DuPree, C., et al. (2009) · Annals of Neurology · doi:10.1002/ana.21641 · Cited by 188
Kreuzaler, M., Rauch, M., Salzer, U., Birmelin, J., Rizzi, M., Grimbacher, B., Plebani, A., Lougaris, V., Quinti, I., Thon, V., et al. (2012) · The Journal of Immunology · doi:10.4049/jimmunol.1102321 · Cited by 183
Warabi, Y., Matsumoto, Y., & Hayashi, H. (2007) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2006.10.008 · Cited by 174
Fingolimod is a potential novel therapy for multiple sclerosis
Aktas, O., Küry, P., Kieseier, B., & Hartung, H.-P. (2010) · Nature Reviews Neurology · doi:10.1038/nrneurol.2010.76 · Cited by 167
The discovery and development of belimumab: the anti-BLyS–lupus connection
Stohl, W., & Hilbert, D. M. (2012) · Nature Biotechnology · doi:10.1038/nbt.2076 · Cited by 166
Immunoglobulins and complement in postmortem multiple sclerosis tissue
Barnett, M. H., Parratt, J. D. E., Cho, E., & Prineas, J. W. (2009) · Annals of Neurology · doi:10.1002/ana.21524 · Cited by 165
Interferon-β increases BAFF levels in multiple sclerosis: implications for B cell autoimmunity
Krumbholz, M., Faber, H., Steinmeyer, F., Hoffmann, L.-A., Kümpfel, T., Pellkofer, H., Derfuss, T., Ionescu, C., Starck, M., Hafner, C., et al. (2008) · Brain · doi:10.1093/brain/awn077 · Cited by 165
Self-citationDifferential effects of fingolimod (FTY720) on immune cells in the CSF and blood of patients with MS
Kowarik, M. C., Pellkofer, H. L., Cepok, S., Korn, T., Kümpfel, T., Buck, D., Hohlfeld, R., Berthele, A., & Hemmer, B. (2011) · Neurology · doi:10.1212/wnl.0b013e3182143564 · Cited by 159
Self-citationHuang, H., Benoist, C., & Mathis, D. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1001074107 · Cited by 159
Functional identification of pathogenic autoantibody responses in patients with multiple sclerosis
Elliott, C., Lindner, M., Arthur, A. T., Brennan, K., Jarius, S., Hussey, J., Chan, A., Salmen, A., Olsson, T. P., Willison, H. J., et al. (2012) · Brain · doi:10.1093/brain/aws105 · Cited by 155
Self-citationThe chemokine CXCL13 (BLC): A putative diagnostic marker for neuroborreliosis
Rupprecht, T., Pfister, H., Angele, B., Kastenbauer, S., Wilske, B., & Koedel, U. (2005) · Neurology · doi:10.1212/01.wnl.0000171349.06645.79 · Cited by 155
BAFF is elevated in serum of patients with Wegener's granulomatosis
Krumbholz, M., Specks, U., Wick, M., Kalled, S. L., Jenne, D. E., & Meinl, E. (2005) · Journal of Autoimmunity · doi:10.1016/j.jaut.2005.08.004 · Cited by 153
Self-citationSmoking is associated with increased lesion volumes and brain atrophy in multiple sclerosis
Zivadinov, R., Weinstock‐Guttman, B., Hashmi, K., Abdelrahman, N. G., Stosic, M., Dwyer, M. G., Hussein, S. M., Durfee, J., & Ramanathan, M. K. (2009) · Neurology · doi:10.1212/wnl.0b013e3181b2a706 · Cited by 148
Krumbholz, M., Theil, D. J., Steinmeyer, F., Cepok, S., Hemmer, B., Hofbauer, M., Farina, C., Derfuss, T. J., Junker, A., Arzberger, T., et al. (2007) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2007.07.024 · Cited by 143
Self-citationThe Chemokine CXCL13 Is a Prognostic Marker in Clinically Isolated Syndrome (CIS)
Brettschneider, J., Czerwoniak, A., Şenel, M., Fang, L., Kassubek, J., Pinkhardt, E. H., Lauda, F., Kapfer, T., Jesse, S., Lehmensiek, V., et al. (2010) · PLoS ONE · doi:10.1371/journal.pone.0011986 · Cited by 143
Gold, R., Stangel, M., & Dalakas, M. C. (2007) · Nature Clinical Practice Neurology · doi:10.1038/ncpneuro0376 · Cited by 139
Obermeier, B., Lovato, L., Mentele, R., Brück, W., Forné, I., Imhof, A., Lottspeich, F., Turk, K. W., Willis, S. N., Wekerle, H., et al. (2011) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2011.01.010 · Cited by 139
Self-citationCerebrospinal Fluid B Cells Correlate with Early Brain Inflammation in Multiple Sclerosis
Kuenz, B., Lutterotti, A., Ehling, R., Gneiss, C., Hämmerle, M., Rainer, C., Deisenhammer, F., Schocke, M. F. H., Berger, T., & Reindl, M. (2008) · PLoS ONE · doi:10.1371/journal.pone.0002559 · Cited by 138
Glatiramer acetate in multiple sclerosis: update on potential mechanisms of action
Farina, C., Weber, M. S., Meinl, E., Wekerle, H., & Hohlfeld, R. (2005) · The Lancet Neurology · doi:10.1016/s1474-4422(05)70167-8 · Cited by 138
Self-citationHeidt, S., Hester, J., Shankar, S., Friend, P. J., & Wood, K. J. (2012) · American Journal of Transplantation · doi:10.1111/j.1600-6143.2012.04012.x · Cited by 130
Atacicept: targeting B cells in multiple sclerosis
Hartung, H., & Kieseier, B. C. (2010) · Therapeutic Advances in Neurological Disorders · doi:10.1177/1756285610371146 · Cited by 129
Effects of FTY720 in MRL-lpr/lpr mice: therapeutic potential in systemic lupus erythematosus.
Okazaki, H., Hirata, D., Kamimura, T., Sato, H., Iwamoto, M., Yoshio, T., Masuyama, J., Fujimura, A., Kobayashi, E., Kano, S., et al. (2002) · PubMed · Cited by 124
Genovese, M. C., Kinnman, N., Bourdonnaye, G. D. L., Rossi, C. P., & Tak, P. P. (2011) · Arthritis & Rheumatism · doi:10.1002/art.30373 · Cited by 123
Glycoproteins as targets of autoantibodies in CNS inflammation: MOG and more
Mayer, M. C., & Meinl, E. (2012) · Therapeutic Advances in Neurological Disorders · doi:10.1177/1756285611433772 · Cited by 123
Self-citationPlanas, R., Jelčić, I., Schippling, S., Martinꝉ, R., & Sospedra, M. (2011) · European Journal of Immunology · doi:10.1002/eji.201142108 · Cited by 116
Meningeal Inflammation is not Associated With Cortical Demyelination in Chronic Multiple Sclerosis
Kooi, E., Geurts, J. J. G., van Horssen, J., Bø, L., & van der Valk, P. (2009) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/nen.0b013e3181b4bf8f · Cited by 116
Tintoré, M., Rovira, A., Brieva, L., Grivé, E., Jardí, R., Borrás, C., & Montalban, X. (2001) · Multiple Sclerosis Journal · doi:10.1177/135245850100700603 · Cited by 113
B cells from glatiramer acetate-treated mice suppress experimental autoimmune encephalomyelitis
Kala, M., Rhodes, S. N., Piao, W.-H., Shi, F., Campagnolo, D. I., & Vollmer, T. L. (2009) · Experimental Neurology · doi:10.1016/j.expneurol.2009.10.015 · Cited by 108
Vitamin D and multiple sclerosis: epidemiology, immunology, and genetics
Simon, K. C., Munger, K. L., & Ascherio, A. (2012) · Current Opinion in Neurology · doi:10.1097/wco.0b013e3283533a7e · Cited by 107
Stohl, W., Metyas, S., Tan, S.-M., Cheema, G. S., Oamar, B., Roschke, V., Wu, Y., Baker, K. P., & Hilbert, D. M. (2004) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2003.018663 · Cited by 105
Sinha, R. K., Park, C., Hwang, I., Davis, M. D., & Kehrl, J. H. (2009) · Immunity · doi:10.1016/j.immuni.2008.12.018 · Cited by 103
The role of differential IgG glycosylation in the interaction of antibodies with FcγRs in vivo
Anthony, R. M., & Nimmerjahn, F. (2010) · Current Opinion in Organ Transplantation · doi:10.1097/mot.0b013e328342538f · Cited by 100
von Büdingen, H. ‐., Harrer, M. D., Kuenzle, S., Meier, M., & Goebels, N. (2008) · European Journal of Immunology · doi:10.1002/eji.200737784 · Cited by 98
BAFF Is Increased in Renal Transplant Patients Following Treatment with Alemtuzumab
Bloom, D. D., Chang, Z., Pauly, K., Kwun, J., Fechner, J. H., Hayes, C. E., Samaniego, M., & Knechtle, S. J. (2009) · American Journal of Transplantation · doi:10.1111/j.1600-6143.2009.02710.x · Cited by 94
Effects of Natalizumab on Circulating B Cells, T Regulatory Cells and Natural Killer Cells
Putzki, N., Baranwal, M., Tettenborn, B., Limmroth, V., & Kreuzfelder, E. (2010) · European Neurology · doi:10.1159/000302687 · Cited by 94
Pashenkov, M. V., Söderström, M. B., & Link, H. (2003) · Journal of Neuroimmunology · doi:10.1016/s0165-5728(02)00441-1 · Cited by 92
Anti-CD20 B-cell depletion enhances monocyte reactivity in neuroimmunological disorders
Lehmann‐Horn, K., Schleich, E., Hertzenberg, D., Hapfelmeier, A., Kümpfel, T., von Bubnoff, N. C. C., Hohlfeld, R., Berthele, A., Hemmer, B., & Weber, M. S. (2011) · Journal of Neuroinflammation · doi:10.1186/1742-2094-8-146 · Cited by 90
Self-citationAntigen‐specific adaptive immune responses in fingolimod‐treated multiple sclerosis patients
Mehling, M., Hilbert, P., Fritz, S., Müller-Durovic, B., Eichin, D., Gasser, O., Kühle, J., Klimkait, T., Lindberg, R. L. P., Kappos, L., et al. (2010) · Annals of Neurology · doi:10.1002/ana.22352 · Cited by 90
Zhang, L., Zheng, S., Wu, H., Wu, Y., Liu, S., Fan, M., & Zhang, J. (2009) · Journal of Neuroscience · doi:10.1523/jneurosci.5040-08.2009 · Cited by 88
Huntington, N. D., Tomioka, R., Clavarino, C., Chow, A. M., Liñares, D., Maña, P., Rossjohn, J., Cachero, T. G., Qian, F., Kalled, S. L., et al. (2006) · International Immunology · doi:10.1093/intimm/dxl080 · Cited by 88
Depletion of B Lymphocytes From Cerebral Perivascular Spaces by Rituximab
Martin, M. D. P., Cravens, P. D., Winger, R. C., Kieseier, B. C., Cepok, S., Eagar, T. N., Zamvil, S. S., Weber, M. S., Frohman, E. M., Kleinschmidt-DeMasters, B. K., et al. (2009) · Archives of Neurology · doi:10.1001/archneurol.2009.157 · Cited by 87
Sharief, M. K., & Thompson, E. J. (1991) · Annals of Neurology · doi:10.1002/ana.410290206 · Cited by 87
Jarius, S., Eichhorn, P., Jacobi, C., Wildemann, B., Wick, M. W., & Voltz, R. (2008) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2008.08.002 · Cited by 83
Brennan, K. M., Galban‐Horcajo, F., Rinaldi, S., O’Leary, C., Goodyear, C. S., Kalna, G., Arthur, A. T., Elliot, C., Barnett, S., Linington, C., et al. (2011) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2011.08.002 · Cited by 77
Implication of perturbed axoglial apparatus in early pediatric multiple sclerosis
Dhaunchak, A. S., Becker, C. H., Schulman, H., de Faria, O., Rajasekharan, S., Banwell, B., Colman, D., Bar‐Or, A., & on behalf of the Canadian Pediatric Demyelinating Disease Group (2011) · Annals of Neurology · doi:10.1002/ana.22693 · Cited by 70
Ho, P. P.-K., Kanter, J. L., Johnson, A. M., Srinagesh, H. K., Chang, E., Purdy, T. M., van Haren, K. P., Wikoff, W. R., Kind, T., Khademi, M., et al. (2012) · Science Translational Medicine · doi:10.1126/scitranslmed.3003831 · Cited by 70
Tak, P. P., Mease, P. J., Genovese, M. C., Kremer, J. M., Haraoui, B. P., Tanaka, Y., Bingham, C. O., Ashrafzadeh, A., Travers, H., Safa‐Leathers, S., et al. (2012) · Arthritis & Rheumatism · doi:10.1002/art.33353 · Cited by 68
Boulton, C., Meiser, K., David, O. J., & Schmouder, R. (2011) · The Journal of Clinical Pharmacology · doi:10.1177/0091270011427908 · Cited by 67
Ireland, S. J., Blazek, M., Harp, C. T., Greenberg, B. M., Frohman, E. M., Davis, L. S., & Monson, N. L. (2012) · Autoimmunity · doi:10.3109/08916934.2012.665529 · Cited by 66
Glucocorticoid-Induced Apoptosis in Early B Cells from Human Bone Marrow
Lill-Elghanian, D. A., Schwartz, K. A., King, L. E., & Fraker, P. J. (2002) · Experimental Biology and Medicine · doi:10.1177/153537020222700907 · Cited by 65
Barnett, M. H., Parratt, J. D. E., Pollard, J. D., & Prineas, J. W. (2009) · PubMed · Cited by 64
Reijmers, R. M., Groen, R. W. J., Kuil, A., Weijer, K. C., Kimberley, F. C., Medema, J. P., Kuppevelt, T. H. V., Li, J., Spaargaren, M., & Pals, S. T. (2011) · Blood · doi:10.1182/blood-2010-12-325522 · Cited by 63
Treatment with glatiramer acetate induces specific IgG4 antibodies in multiple sclerosis patients
Farina, C., Vargas, V., Heydari, N., Kümpfel, T., Meinl, E., & Hohlfeld, R. (2002) · Journal of Neuroimmunology · doi:10.1016/s0165-5728(01)00490-8 · Cited by 61
Self-citationImmunological Markers of Optimal Response to Natalizumab in Multiple Sclerosis
Villar, L. M. (2012) · Archives of Neurology · doi:10.1001/archneurol.2011.971 · Cited by 60
Induction of apoptosis by dexamethasone in the B cell lineage
Andréau, K., Lemaire, C., Souvannavong, V., & Adam, A. (1998) · Immunopharmacology · doi:10.1016/s0162-3109(98)00034-4 · Cited by 59
Begum-Haque, S., Christy, M., Ochoa‐Repáraz, J., Nowak, E. C., Mielcarz, D. W., Haque, A., & Kasper, L. H. (2010) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2010.10.031 · Cited by 55
Cameron, E. M., Spencer, S. M., Lazarini, J., Harp, C. T., Ward, E. S., Burgoon, M. P., Owens, G. P., Racke, M. K., Bennett, J. L., Frohman, E. M., et al. (2009) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2009.05.014 · Cited by 54
Lambracht‐Washington, D., O’Connor, K. C., Cameron, E. M., Jowdry, A. L., Ward, E. S., Frohman, E. M., Racke, M. K., & Monson, N. L. (2007) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2007.03.002 · Cited by 52
Knippenberg, S. A. M., Smolders, J., Thewissen, M. M., Peelen, E., Tervaert, J. W. C., Hupperts, R., & Damoiseaux, J. G. M. C. (2011) · Multiple Sclerosis Journal · doi:10.1177/1352458511412655 · Cited by 51
Vaknin‐Dembinsky, A., Brill, L., Yosha‐Orpaz, N., Abramsky, O., & Karussis, D. M. (2010) · Multiple Sclerosis Journal · doi:10.1177/1352458510380416 · Cited by 50
Fusby, J. S., Kassmeier, M. D., Palmer, V., Perry, G. A., Anderson, D. K., Hackfort, B. T., Alvarez, G., Cullen, D. M., Akhter, M. P., & Swanson, P. C. (2010) · Inhalation Toxicology · doi:10.3109/08958378.2010.483258 · Cited by 46
FTY720 suppresses humoral immunity by inhibiting germinal center reaction
Han, S., Zhang, X., Wang, G., Guan, H., García, G., Li, P., Feng, L., & Zheng, B. Q. (2004) · Blood · doi:10.1182/blood-2004-06-2075 · Cited by 45
Jones, J., & Coles, A. J. (2009) · PubMed · Cited by 34
BAFF is a Biological Response Marker to IFN-β Treatment in Multiple Sclerosis
Gandhi, K. S., McKay, F. C., Schibeci, S. D., Arthur, J. W., Heard, R. N., Stewart, G. J., & Booth, D. R. (2008) · Journal of Interferon & Cytokine Research · doi:10.1089/jir.2008.0007 · Cited by 30
Kantor, A. B., Deng, J., Waubant, E. L., Lin, H., Becker, C. H., Lacy, J. R., Perrone, A. M., Bennett, D., & Goelz, S. E. (2007) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2007.05.009 · Cited by 29
Accelerated central nervous system autoimmunity in BAFF-receptor-deficient mice
Kim, S. S., Richman, D. P., Zamvil, S. S., & Agius, M. A. (2011) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2011.04.008 · Cited by 28
Pan, F., Yang, T., Chen, X., Chen, Y., Gao, G., Liu, Y.-Z., Pei, Y.-F., Sha, B. Y., Jiang, Y. J., Xu, C., et al. (2010) · Immunogenetics · doi:10.1007/s00251-010-0431-6 · Cited by 27
Hohlfeld, R., Barkhof, F., & Polman, C. H. (2011) · Neurology · doi:10.1212/wnl.0b013e31820db40f · Cited by 26
Self-citationMotyka, B., Bhogal, H. S., & Reynolds, J. D. (1995) · European Journal of Immunology · doi:10.1002/eji.1830250711 · Cited by 25
Lesesve, J.-F., Debouverie, M., Bittencourt, M. D. C., & Béné, M. C. (2011) · Bone Marrow Transplantation · doi:10.1038/bmt.2010.328 · Cited by 22
Anderson, A. E., Lorenzi, A. R., Pratt, A. G., Wooldridge, T., Diboll, J., Hilkens, C. M. U., & Isaacs, J. D. (2012) · Rheumatology · doi:10.1093/rheumatology/kes038 · Cited by 20
Ligocki, A. J., Lovato, L., Xiang, D., Guidry, P. A., Scheuermann, R. H., Willis, S. N., Almendinger, S. E., Racke, M. K., Frohman, E. M., Hafler, D. A., et al. (2010) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2010.06.016 · Cited by 20
FTY720 in Corneal Concordant Xenotransplantation
Sedláková, K., Muckersie, E., Robertson, M. B., Filipec, M., & Forrester, J. V. (2005) · Transplantation · doi:10.1097/01.tp.0000151005.37985.de · Cited by 16
Zanotti, C., Chiarini, M., Serana, F., Capra, R., Rottoli, M., Rovaris, M., Cavaletti, G., Clerici, R., Rezzonico, M., Caimi, L., et al. (2011) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2011.10.007 · Cited by 15
Palmer, V., Kassmeier, M. D., Willcockson, J. R., Akhter, M. P., Cullen, D. M., & Swanson, P. C. (2011) · PLoS ONE · doi:10.1371/journal.pone.0024804 · Cited by 12
Diagnostic criteria for primary progressive mutiple sclerosis: a position paper.
(2000) · Pure Amsterdam UMC · doi:10.1002/1531-8249(200006)47:6 · Cited by 2
Cited by
Memory B Cells Activate Brain-Homing, Autoreactive CD4+ T Cells in Multiple Sclerosis
Jelcic, I., Al Nimer, F., Wang, J., Lentsch, V., Planas, R., Jelcic, I., Madjovski, A., Ruhrmann, S., Faigle, W., Frauenknecht, K., et al. (2018) · Cell · doi:10.1016/j.cell.2018.08.011 · Cited by 508
Reassessing B cell contributions in multiple sclerosis
Li, R., Patterson, K. R., & Bar-Or, A. (2018) · Nature Immunology · doi:10.1038/s41590-018-0135-x · Cited by 401
Androgen-Induced Immunosuppression
Gubbels Bupp, M. R., & Jorgensen, T. N. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.00794 · Cited by 390
γ-secretase directly sheds the survival receptor BCMA from plasma cells
Laurent, S. A., Hoffmann, F. S., Kuhn, P.-H., Cheng, Q., Chu, Y., Schmidt-Supprian, M., Hauck, S. M., Schuh, E., Krumbholz, M., Rübsamen, H., et al. (2015) · Nature Communications · doi:10.1038/ncomms8333 · Cited by 377
Self-citationThe spectrum of MOG autoantibody-associated demyelinating diseases
Reindl, M., Di Pauli, F., Rostásy, K., & Berger, T. (2013) · Nature Reviews Neurology · doi:10.1038/nrneurol.2013.118 · Cited by 375
Metadata
- Authors
- Krumbholz, M., Derfuss, T., Hohlfeld, R., & Meinl, E.
- Venue
- Nature Reviews Neurology
- Published
- 2012-10-09
- Volume
- 8
- Issue
- 11
- Pages
- 613-623
- ISSN
- 1759-4758 (ISSN-L)
- 1759-4766
- OpenAlex
- W1995353727
- Cited by
- 267
- References
- 150
- FWCI
- 4.41
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.